Skip to Main Content
Our specialists
Find specialists supported by world-renowned researchers & educators.
>
See our specialists
Where to find us
See a map of Clinic Locations
>
Clinical Locations
Referrals
Information for referring doctors
>
Refer a patient

Yale Cancer Center at Smilow Cancer Hospital

Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute—and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.

Fact Sheets

News from Yale Medicine

In the News

Clinical Trials

Prostate Cancer, Phase 1 Cancers

A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination With Immuno-Oncology Agents in Subjects With Unresectable Advanced or Metastatic Solid Tumors

AgeANY
GenderANY
Date1 August
Sarcoma Cancers

A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma

AgeANY
GenderANY
Date19 December
Colorectal Cancer, Stomach and Esophagus

A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis

AgeANY
GenderANY
Date6 February
Kidney Cancer

A First-in-Human, Phase 1 Dose Escalation and Dose Expansion Trial to Assess the Safety and Tolerability of COM503 as Monotherapy and in Combination Therapy in Participants With Advanced Solid Malignancies

AgeANY
GenderANY
Date21 November